 The purpose of this grant is to evaluate the efficacy of sodium butyrate as a novel treatment for cognitive deficits in schizophrenia SZ. Sodium butyrate is a short chain fatty acid and binds to the zinc site of histone deacetylases HDAC. The inhibition of HDAC results in histone hyperacetylation. 